Jiangsu Hengui Forms Cancer Collaboration with Albert Einstein College

Jiangsu Hengrui Medicine announced a research agreement with Albert Einstein College of Medicine of New York City to advance cancer treatment. The multi-year cancer research effort brings together the scientific insights of Einstein with the clinical ability of Hengrui. Professor XingXing Zang of Einstein, who conducts research into cancer immunotherapies, also said he has struck a deal with Hengrui, though it is not clear that his work constitutes all of Hengrui's relationship with the college. More details.... Stock Symbol: (SHA: 600276) Share this with colleagues: // //